ATE511539T1 - Bhlh-pas-proteine, deren gene und verwendung derselben - Google Patents
Bhlh-pas-proteine, deren gene und verwendung derselbenInfo
- Publication number
- ATE511539T1 ATE511539T1 AT01272819T AT01272819T ATE511539T1 AT E511539 T1 ATE511539 T1 AT E511539T1 AT 01272819 T AT01272819 T AT 01272819T AT 01272819 T AT01272819 T AT 01272819T AT E511539 T1 ATE511539 T1 AT E511539T1
- Authority
- AT
- Austria
- Prior art keywords
- amino acid
- regulatory factor
- transcription regulatory
- level
- neurocyte
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 title 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 3
- 230000001105 regulatory effect Effects 0.000 abstract 3
- 238000013518 transcription Methods 0.000 abstract 3
- 230000035897 transcription Effects 0.000 abstract 3
- 230000001419 dependent effect Effects 0.000 abstract 2
- 210000004962 mammalian cell Anatomy 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- 239000003550 marker Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000037361 pathway Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5058—Neurological cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000398548 | 2000-12-27 | ||
| JP2001077740 | 2001-03-19 | ||
| PCT/JP2001/011064 WO2002053729A1 (fr) | 2000-12-27 | 2001-12-17 | Proteines bhlh, leurs genes et leurs utilisations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE511539T1 true ATE511539T1 (de) | 2011-06-15 |
Family
ID=26606895
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01272819T ATE511539T1 (de) | 2000-12-27 | 2001-12-17 | Bhlh-pas-proteine, deren gene und verwendung derselben |
| AT01272511T ATE393168T1 (de) | 2000-12-27 | 2001-12-17 | Transkriptionsaktivierungskomplex und dessen verwendung |
| AT01272818T ATE397664T1 (de) | 2000-12-27 | 2001-12-17 | Verfahren zur untersuchung der fähigkeit zur kontrolle der nervenzellplastizität |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01272511T ATE393168T1 (de) | 2000-12-27 | 2001-12-17 | Transkriptionsaktivierungskomplex und dessen verwendung |
| AT01272818T ATE397664T1 (de) | 2000-12-27 | 2001-12-17 | Verfahren zur untersuchung der fähigkeit zur kontrolle der nervenzellplastizität |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US20040110171A1 (de) |
| EP (3) | EP1354951B1 (de) |
| AT (3) | ATE511539T1 (de) |
| CA (3) | CA2433492A1 (de) |
| DE (2) | DE60133774T2 (de) |
| WO (3) | WO2002053736A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030190653A1 (en) * | 2002-01-11 | 2003-10-09 | Mehrdad Shamloo | Regulated gene in the pathophysiology of ischemic stroke |
| WO2006026485A2 (en) | 2004-08-25 | 2006-03-09 | Isis Pharmaceuticals, Inc. | Modulation of hif1-beta expression |
| JP2007282501A (ja) * | 2006-03-24 | 2007-11-01 | Sumitomo Chemical Co Ltd | アポトーシス制御能力の検定方法 |
| JP2007282502A (ja) * | 2006-03-24 | 2007-11-01 | Sumitomo Chemical Co Ltd | 細胞変性制御能力の検定方法 |
| US11889986B2 (en) | 2010-12-09 | 2024-02-06 | Endochoice, Inc. | Flexible electronic circuit board for a multi-camera endoscope |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2757524B1 (fr) * | 1996-12-19 | 1999-01-29 | Rhone Poulenc Rorer Sa | Polypeptides de la famille bhlh, sequences d'acides nucleiques correspondantes |
| US5840532A (en) | 1997-01-21 | 1998-11-24 | Board Of Regents, The University Of Texas System | Neuronal bHLH-PAS domain proteins |
| AU1610499A (en) * | 1997-11-28 | 1999-06-16 | Wisconsin Alumni Research Foundation | Cdnas and proteins belonging to the bhlh-pas superfamily of transcription regulators, and methods of use |
| US6780642B2 (en) * | 2000-08-04 | 2004-08-24 | Florida Atlantic University | Association of SIM2 with cancer |
| US20030190653A1 (en) * | 2002-01-11 | 2003-10-09 | Mehrdad Shamloo | Regulated gene in the pathophysiology of ischemic stroke |
-
2001
- 2001-12-17 US US10/451,923 patent/US20040110171A1/en not_active Abandoned
- 2001-12-17 EP EP01272818A patent/EP1354951B1/de not_active Expired - Lifetime
- 2001-12-17 WO PCT/JP2001/011063 patent/WO2002053736A1/ja not_active Ceased
- 2001-12-17 CA CA002433492A patent/CA2433492A1/en not_active Abandoned
- 2001-12-17 AT AT01272819T patent/ATE511539T1/de not_active IP Right Cessation
- 2001-12-17 AT AT01272511T patent/ATE393168T1/de not_active IP Right Cessation
- 2001-12-17 DE DE60133774T patent/DE60133774T2/de not_active Expired - Lifetime
- 2001-12-17 EP EP01272819A patent/EP1354946B1/de not_active Expired - Lifetime
- 2001-12-17 CA CA2433495A patent/CA2433495C/en not_active Expired - Fee Related
- 2001-12-17 WO PCT/JP2001/011064 patent/WO2002053729A1/ja not_active Ceased
- 2001-12-17 AT AT01272818T patent/ATE397664T1/de not_active IP Right Cessation
- 2001-12-17 CA CA2433501A patent/CA2433501C/en not_active Expired - Fee Related
- 2001-12-17 US US10/465,920 patent/US7129065B2/en not_active Expired - Fee Related
- 2001-12-17 DE DE60134342T patent/DE60134342D1/de not_active Expired - Lifetime
- 2001-12-17 EP EP01272511A patent/EP1354889B1/de not_active Expired - Lifetime
- 2001-12-17 US US10/465,914 patent/US7541189B2/en not_active Expired - Fee Related
- 2001-12-17 WO PCT/JP2001/011062 patent/WO2002053735A1/ja not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP1354889A1 (de) | 2003-10-22 |
| ATE397664T1 (de) | 2008-06-15 |
| EP1354951A4 (de) | 2004-12-29 |
| EP1354889A4 (de) | 2004-12-29 |
| US20040110171A1 (en) | 2004-06-10 |
| EP1354946A4 (de) | 2005-01-05 |
| ATE393168T1 (de) | 2008-05-15 |
| CA2433501A1 (en) | 2002-07-11 |
| EP1354946A1 (de) | 2003-10-22 |
| EP1354951B1 (de) | 2008-06-04 |
| EP1354951A1 (de) | 2003-10-22 |
| WO2002053736A1 (fr) | 2002-07-11 |
| US7129065B2 (en) | 2006-10-31 |
| CA2433492A1 (en) | 2002-07-11 |
| CA2433501C (en) | 2011-07-19 |
| EP1354889B1 (de) | 2008-04-23 |
| CA2433495C (en) | 2011-10-18 |
| WO2002053729A1 (fr) | 2002-07-11 |
| CA2433495A1 (en) | 2002-07-11 |
| EP1354946B1 (de) | 2011-06-01 |
| WO2002053735A1 (fr) | 2002-07-11 |
| DE60133774D1 (de) | 2008-06-05 |
| US20040248247A1 (en) | 2004-12-09 |
| US7541189B2 (en) | 2009-06-02 |
| US20060216705A1 (en) | 2006-09-28 |
| DE60134342D1 (de) | 2008-07-17 |
| DE60133774T2 (de) | 2009-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE211506T1 (de) | Ein verfahren zum nachweis biologisch aktiver substanzen | |
| ATE488588T1 (de) | Verfahren zur kennzeichnung mesenchymaler stammzellen unter verwendung verschiedener marker | |
| NO308312B1 (no) | FremgangsmÕte til fremstilling av et kimerisk protein, DNA- molekyl som koder proteinet, rekombinant DNA-molekyl og celle som omfatter DNA-molekylet | |
| WO2003078962A3 (en) | Detection and quantification of modified proteins | |
| EP1170380A3 (de) | Zusammensetzungen und Verfahren zur Bestimmung antiviraler Wirkstoff Suszeptibilität und Resistenz sowie antivirales Wirkstoff-Screening | |
| DE60035681D1 (de) | Optische sonden und assays zur messung der proteinphosphorylierung | |
| ATE393168T1 (de) | Transkriptionsaktivierungskomplex und dessen verwendung | |
| ATE414701T1 (de) | Fluoreszenzsonden zur verwendung bei einem bindungsassay auf proteinkinaseinhibitoren | |
| ATE412775T1 (de) | Verfahren zur quantifizierung von nukleinsäuren mittels bestimmung der zellzahl | |
| CA2044626A1 (en) | Type a platelet-derived growth factor receptor gene | |
| ATE312939T1 (de) | Verfahren zur rekombinanten herstellung von polypeptiden | |
| ATE491037T1 (de) | Verfahren zum zählen von bakterien, bakterienzählgerät und für das zählgerät vewendete zelle | |
| ATE348190T1 (de) | Verfahren zum nachweis von protein- proteininteraktionen in membranen | |
| ATE421693T1 (de) | Proteine in der diabetes-proteomanalyse | |
| Cross et al. | Evaluation of relationship between plasma fibrinogen concentration and tuberculin testing in red deer | |
| RU2008152780A (ru) | Ген, вовлеченный в иммортализацию раковой клетки человека, и его применение | |
| AU2001276569B2 (en) | Quantitative fluorescent assay for determining the activity of transport proteins | |
| FR2786787B1 (fr) | Methode d'analyse in vitro d'un phenotype connu a partir d'un echantillon d'acides nucleiques | |
| DK1143011T3 (da) | Fremgangsmåde til påvisning af biologisk aktive substanser | |
| Meer | Smooth muscle myosin heavy chain isoform levels and unloaded shortening in single smooth muscle cells | |
| TW200407334A (en) | Trehalose receptor and method of detecting trehalose using the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |